To further explore the identity of Egr2-expressing BC cells and their derivatives, we first analyzed E12.5 ventral nerve roots to assess whether all Tom-positive cells were expressing the glial marker Sox10, at the protein or mRNA levels (Figure 3A–C). The gene discussed is EGR2; the disease is breast cancer.